Cargando…

Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease

PURPOSE: Increased type I interferon is considered relevant to the pathology of a number of monogenic and complex disorders spanning pediatric rheumatology, neurology, and dermatology. However, no test exists in routine clinical practice to identify enhanced interferon signaling, thus limiting the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Gillian I., Melki, Isabelle, Frémond, Marie-Louise, Briggs, Tracy A., Rodero, Mathieu P., Kitabayashi, Naoki, Oojageer, Anthony, Bader-Meunier, Brigitte, Belot, Alexandre, Bodemer, Christine, Quartier, Pierre, Crow, Yanick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325846/ https://www.ncbi.nlm.nih.gov/pubmed/27943079 http://dx.doi.org/10.1007/s10875-016-0359-1

Ejemplares similares

Detection of interferon alpha protein reveals differential levels and cellular sources in disease
por: Rodero, Mathieu P., et al.
Publicado: (2017)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Enhanced cGAS-STING–dependent interferon signaling associated with mutations in ATAD3A
por: Lepelley, Alice, et al.
Publicado: (2021)

Assessment of type I interferon response in routine practice in France in 2022
por: Nombel, Anais, et al.
Publicado: (2023)

Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
por: Rodero, Mathieu Paul, et al.
Publicado: (2021)

Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
por: Rodero, Mathieu Paul, et al.
Publicado: (2021)

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
por: Llibre, Alba, et al.
Publicado: (2018)

Mutations in CECR1 associated with a neutrophil signature in peripheral blood
por: Belot, Alexandre, et al.
Publicado: (2014)

JAK Inhibition in Juvenile Idiopathic Arthritis (JIA): Better Understanding of a Promising Therapy for Refractory Cases
por: Melki, Isabelle, et al.
Publicado: (2023)

Type I interferon-mediated autoinflammation due to DNase II deficiency
por: Rodero, Mathieu P., et al.
Publicado: (2017)

Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of Vaccination
por: David, Emmanuelle, et al.
Publicado: (2022)

Clinical characteristics, management and outcomes in patients with juvenile dermatomyositis requiring admission in pediatric intensive care unit
por: Besancon, Alix, et al.
Publicado: (2014)

Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis
por: Frémond, M-L, et al.
Publicado: (2015)

Juvenile overlap myositis: retrospective study about 20 cases
por: Piccolo, Vanessa Remy, et al.
Publicado: (2014)

Probable DRESS syndrome induced by IL-1 inhibitors
por: Polivka, L., et al.
Publicado: (2017)

COPA Syndrome as a Cause of Lupus Nephritis
por: Boulisfane-El Khalifi, Siham, et al.
Publicado: (2019)

Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre
por: Goirand, Maxime, et al.
Publicado: (2018)

Mitochondrial Nucleic Acid as a Driver of Pathogenic Type I Interferon Induction in Mendelian Disease
por: Lepelley, Alice, et al.
Publicado: (2021)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

PW03-033 - SLC29A3 mutation: a new autoinflammatory condition
por: Melki, I, et al.
Publicado: (2013)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS
por: Gratia, Matthieu, et al.
Publicado: (2019)

Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers
por: Labouret, Mathilde, et al.
Publicado: (2022)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination
por: Collignon, C., et al.
Publicado: (2022)

Pediatric systemic lupus erythematosus and human parvovirus B19 infection
por: Bélien-Pallet, V, et al.
Publicado: (2011)

ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters
por: Uettwiller, F, et al.
Publicado: (2016)

Safety of rituximab in children with auto-immune diseases
por: Bader-Meunier, B, et al.
Publicado: (2008)

The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Quartier, Pierre, et al.
Publicado: (2018)

PRKDC mutations associated with immunodeficiency, granuloma and aire-dependent autoimmunity
por: Belot, Alexandre, et al.
Publicado: (2014)

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment
por: Smith, Nikaïa, et al.
Publicado: (2019)

Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling
por: Lepelley, Alice, et al.
Publicado: (2020)

LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages
por: Omarjee, Ommar, et al.
Publicado: (2021)

JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study
por: Frémond, Marie-Louise, et al.
Publicado: (2023)

The SKIV2L RNA exosome limits activation of the RIG-I-like receptors
por: Eckard, Sterling C., et al.
Publicado: (2014)

Clinical non-penetrance associated with biallelic mutations in the RNase H2 complex
por: Crow, Yanick J
Publicado: (2023)

Caractéristiques cliniques de la Covid-19 chez les enfants et adolescents atteints de maladies rhumatismales et inflammatoires : données de la cohorte française RMD COVID-19 de 95 patients
por: Mammou Mraghni, S., et al.
Publicado: (2021)

Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis
por: Bekaddour, Nassima, et al.
Publicado: (2023)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1mnbp2svk7kk3nvaq8qtpb4duo